Back
PetMed Express Vs. Oruka Therapeutics Industry Stock Comparison
Sell
39
PETS
PetMed Express
Last Price:
4.78
Seasonality Move:
6.42%
Sell
20
ORKA
Oruka Therapeutics
Last Price:
20.54
Seasonality Move:
--
Sell
39
PetMed Express (PETS)
is a Sell
Is PetMed Express a Buy, Sell or Hold?
- The current PetMed Express [PETS] share price is $4.78. The Score for PETS is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- PETS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
Oruka Therapeutics (ORKA)
is a Sell
Is Oruka Therapeutics a Buy, Sell or Hold?
- The current Oruka Therapeutics [ORKA] share price is $20.75. The Score for ORKA is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- ORKA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
PETS Stock Price Chart
What is PetMed Express's stock price today?
-
The PetMed Express share price today is $4.78
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PETS is experiencing slight buying pressure.
ORKA Stock Price Chart
What is Oruka Therapeutics's stock price today?
-
The Oruka Therapeutics share price today is $20.75
The current trend is moderately bearish and ORKA is experiencing slight buying pressure.
PETS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.18 | Buy |
| Relative Strength Index (14 RSI): | 55.78 | Buy |
| Chaikin Money Flow: | 18056 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.96 - 5.06) | Buy |
| Bollinger Bands (100): | (3.27 - 4.39) | Buy |
ORKA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.7 | Sell |
| Relative Strength Index (14 RSI): | 31.86 | Sell |
| Chaikin Money Flow: | 87639 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.29 - 29.47) | Sell |
| Bollinger Bands (100): | ( - ) | Buy |
PETS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.76 | Buy |
| 20-day SMA: | 4.66 | Buy |
| 50-day SMA: | 4.15 | Buy |
| 200-day SMA: | 4.19 | Buy |
| 8-day EMA: | 4.73 | Buy |
| 20-day EMA: | 4.62 | Buy |
| 50-day EMA: | 4.27 | Buy |
| 200-day EMA: | 4.96 | Sell |
ORKA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.54 | Sell |
| 20-day SMA: | 25.55 | Sell |
| 50-day SMA: | 26.16 | Sell |
| 200-day SMA: | 0 | Buy |
| 8-day EMA: | 22.46 | Sell |
| 20-day EMA: | 24.55 | Sell |
| 50-day EMA: | 11.44 | Buy |
| 200-day EMA: | 3.62 | Buy |
PetMed Express Earnings Growth & PETS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.34 per share, and an increase next year of $0.66 per share.
Oruka Therapeutics Earnings Growth & ORKA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $1.23 per share.
PetMed Express Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Oruka Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||